UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.268-275

2015

Volltextzugriff (PDF)

The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus

Acta diabetologica, 2014-02, Vol.51 (1), p.123-131

2014

Volltextzugriff (PDF)

Rosiglitazone decreases albuminuria in type 2 diabetic patients

Kidney international, 2007-12, Vol.72 (11), p.1367-1373

2007

Volltextzugriff (PDF)

Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects

The journal of clinical endocrinology and metabolism, 2011-06, Vol.96 (6), p.1763-1770

2011

Volltextzugriff (PDF)

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

Diabetologia, 2009-04, Vol.52 (4), p.723-732

2009

Volltextzugriff (PDF)

Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus

Expert opinion on pharmacotherapy, 2015-12, Vol.16 (18), p.2819-2833

2015

Volltextzugriff (PDF)

The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo

Diabetic medicine, 2015-05, Vol.32 (5), p.657-664

2015

Volltextzugriff (PDF)

Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus

Clinical pharmacology and therapeutics, 2007-09, Vol.82 (3), p.275-281

2007

Volltextzugriff (PDF)

Metabolic effects of muraglitazar in type 2 diabetic subjects

Diabetes, obesity & metabolism, 2011-10, Vol.13 (10), p.893-902

2011

Volltextzugriff (PDF)

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

Diabetes/metabolism research and reviews, 2011-05, Vol.27 (4), p.373-382

2011

Volltextzugriff (PDF)

Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans

Diabetes (New York, N.Y.), 2000-07, Vol.49 (7), p.1186-1193

2000

Volltextzugriff (PDF)

Istituzioni, capitale sociale e sviluppo locale

Cersosimo, Domenico

2001

Volltextzugriff (PDF)

842 PREDISPOSITION TO DEVELOP DIABETES IN SUBJECTS WITH NAFLD IS RELATED TO INSULIN RESISTANCE RATHER THAN TO DECREASED B-CELL FUNCTION

Journal of hepatology, 2011-03, Vol.54, p.S336-S337

2011

Volltextzugriff (PDF)

Renal glucose production during insulin-induced hypoglycemia in humans

Diabetes (New York, N.Y.), 1999-02, Vol.48 (2), p.261

1999

Volltextzugriff (PDF)

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

The journal of clinical endocrinology and metabolism, 2004-01, Vol.89 (1), p.200-206

2004

Volltextzugriff (PDF)

Insulin regulation of renal glucose metabolism in conscious dogs

The Journal of clinical investigation, 1994-06, Vol.93 (6), p.2584-2589

1994

Volltextzugriff (PDF)

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1364-1370

2003

Volltextzugriff (PDF)

Regulation of splanchnic and renal substrate supply by insulin in humans

Metabolism, clinical and experimental, 2000-05, Vol.49 (5), p.676-683

2000

Volltextzugriff (PDF)

Effects of the Use of Functional Electro-Stimulation (FES) on the Physiological Cost, Speed and Capacity of Gait After Stroke

Converging Clinical and Engineering Research on Neurorehabilitation II, 2017-01, p.1457-1461

2017

Volltextzugriff (PDF)

O1 Mode d’action de l’exénatide sur la réduction des glycémies post-prandiales dans le diabète de type 2

Diabetes & metabolism, 2008, Vol.34, p.H9-H9

2008

Volltextzugriff (PDF)

Renal lactate metabolism and gluconeogenesis during insulin-induced hypoglycemia

Diabetes (New York, N.Y.), 1998-07, Vol.47 (7), p.1101

1998

Volltextzugriff (PDF)

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E fficacy and D urability of I nitial C ombination T herapy for T ype 2 D iabetes ( EDICT ): a randomized trial

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.268-275

2015

Volltextzugriff (PDF)

Effects of pulsatile delivery of basal growth hormone on lipolysis in humans

American journal of physiology: endocrinology and metabolism, 1996-07, Vol.271 (1), p.E123-E126

1996

Volltextzugriff (PDF)

Dose-Response Effect of a Single Administration of Oral Hexyl-Insulin Monoconjugate 2 in Healthy Nondiabetic Subjects

Diabetes care, 2004-12, Vol.27 (12), p.2868-2873

2004

Volltextzugriff (PDF)

Insulin regulation of renal glucose metabolism in humans

American journal of physiology: endocrinology and metabolism, 1999-01, Vol.276 (1), p.E78-E84

1999

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(74)
Humans
(68)
Male
(58)
Female
(56)
Biological And Medical Sciences
(49)
Adult
(35)
Middle Aged
(33)
Medical Sciences
(28)
Endocrinology & Metabolism
(27)
Fundamental And Applied Biological Sciences. Psychology
(24)
Animals
(21)
Blood Glucose - Metabolism
(19)
Insulin - Blood
(19)
Neurosciences & Neurology
(17)
Aged
(16)
Diabetes
(15)
Kidney - Metabolism
(14)
Clinical Neurology
(13)
Dogs
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial

The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus

Rosiglitazone decreases albuminuria in type 2 diabetic patients

Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus

The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo

Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus

Metabolic effects of muraglitazar in type 2 diabetic subjects

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans

Istituzioni, capitale sociale e sviluppo locale

842 PREDISPOSITION TO DEVELOP DIABETES IN SUBJECTS WITH NAFLD IS RELATED TO INSULIN RESISTANCE RATHER THAN TO DECREASED B-CELL FUNCTION

Renal glucose production during insulin-induced hypoglycemia in humans

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Insulin regulation of renal glucose metabolism in conscious dogs

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Regulation of splanchnic and renal substrate supply by insulin in humans

Effects of the Use of Functional Electro-Stimulation (FES) on the Physiological Cost, Speed and Capacity of Gait After Stroke

O1 Mode d’action de l’exénatide sur la réduction des glycémies post-prandiales dans le diabète de type 2

Renal lactate metabolism and gluconeogenesis during insulin-induced hypoglycemia

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E fficacy and D urability of I nitial C ombination T herapy for T ype 2 D iabetes ( EDICT ): a randomized trial

Effects of pulsatile delivery of basal growth hormone on lipolysis in humans

Dose-Response Effect of a Single Administration of Oral Hexyl-Insulin Monoconjugate 2 in Healthy Nondiabetic Subjects

Insulin regulation of renal glucose metabolism in humans

Suchergebnisse filtern